Press / media

As an institution of application-oriented research, the Fraunhofer Institute for Cell Therapy and Immunology IZI attaches great importance to informing customers and the public.

22.2.2023

Fraunhofer IZI contributes expertise to Germany's largest collaborative project on mosquito research

The interdisciplinary joint project CuliFo combines field and laboratory research on mosquitoes, Latin Culicidae, in Germany. Climatic changes increase the risk that exotic mosquitoes occur in our latitudes.
Read more

13.2.2023

GLP test facility of the Fraunhofer IZI certified for test category 2 since January 2023

The GLP test facility of the Fraunhofer Institute for Cell Therapy and Immunology has been certified for testing category 9 "Safety testing of ATMPs - immunotoxicity / immunogenicity, biodistribution and tumorigenicity in vitro / in vivo" since 2009. Since January 2023, the testing category 2 "Toxicity studies" is now also part of the portfolio.
Read more

20.12.2022

Software development expands portfolio of RIBOLUTION Biomarker Center at Fraunhofer IZI

Audit confirms RIBOLUTION Biomarker Center at Fraunhofer IZI the successful implementation of software development processes for medical devices software (according to IEC 62304 and ISO 14971).
Read more

15.12.2022

Hydrogels for tissue engineering

For the development and behavior of cells, their biomechanical environment is as important as biochemical signaling molecules. In the body, biomechanical stimuli are exerted in particular by the extracellular matrix, which provides shape to tissues and surrounds many cell types.
Read more

Archive news and press releases

RSS Newsfeed

Get the latest news about the Fraunhofer IZI. Through our RSS-feed you have the opportunity to follow all our press releases and receive them right when they are published.

Social media

 

Media library

 

Publications

 

Events